Aerie Pharmaceuticals Inc., of Durham, N.C., appointed Peter J. McDonnell to its board. He will also serve on the nominating and corporate governance and compensation committees.
Affimed NV, of Heidelberg, Germany, appointed Angus Smith chief financial officer, effective July 13, 2020.
Amag Pharmaceuticals Inc., of Waltham, Mass, appointed Brian Piekos interim chief financial officer and Anthony Casciano chief operating officer.
Arvinas Inc., of New Haven, Conn., appointed Linda Bain to its board.
Dyne Therapeutics Inc., of Waltham, Mass., appointed Daniel Wilson vice president, head of intellectual property.
Glyscend Therapeutics, of Baltimore, appointed Karen Talmadge to its board.
Quell Therapeutics Ltd., of London, appointed Dhaval Patel and Robert Lechler to its board. It also named Natalie Belmonte senior vice president research and translation.
Praxis Precision Medicines Inc., of Cambridge, Mass., appointed Stuart Chaffee chief financial officer.
Rockwell Medical Inc., of Wixom, Mich., appointed Allen R. Nissenson to its board.
X4 Pharmaceuticals Inc., of Cambridge, Mass., appointed Renato Skerlj chief scientific officer.